COMMUNIQUÉ DE PRESSE
News
-
-
-
COMMUNIQUÉ DE PRESSE
Transgene - First Patient Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating Lead Cancer Vaccine TG4050 in Head and Neck Cancer
Transgene enrolls first patient in Phase II of randomized Phase I/II trial for cancer vaccine TG4050 in head and neck cancer, with completion expected in Q4 2025 -
-
-
-
COMMUNIQUÉ DE PRESSE
Orascom Development Holding AG: enters into an agreement for the sale of RAK Tourism Investment FZC in the UAE for a total enterprise value of USD 40 million
Orascom Development Holding AG enters into a binding agreement to sell RAK Tourism Investment FZC in the UAE for USD 40 million. Transaction includes cash proceeds and debt assumption -
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Vulcan Energy Resources Limited: Vulcan Energy signs agreements with CIMIC Group, Hancock Prospecting and Victor Smorgon Group for a total equity investment of EUR 40 million
Vulcan Energy Resources Limited signs agreements with CIMIC Group, Hancock Prospecting, and Victor Smorgon Group for a total equity investment of EUR 40 million to fund Phase One lithium plant validation works and other activities
